Yunnan Baiyao Group Co.,Ltd (SHE:000538)
China · Delayed Price · Currency is CNY 55.88
-0.03 (-0.05%)
Apr 8, 2026, 12:24 PM CST
SHE:000538 Revenue
In the year 2025, Yunnan Baiyao Group Co.,Ltd had annual revenue of 41.19B CNY with 2.88% growth. Yunnan Baiyao Group Co.,Ltd had revenue of 10.53B in the quarter ending December 31, 2025, with 4.10% growth.
Revenue
41.19B
Revenue Growth
+2.88%
P/S Ratio
2.42
Revenue / Employee
4.44M
Employees
9,277
Market Cap
99.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 41.19B | 1.15B | 2.88% |
| Dec 31, 2024 | 40.03B | 922.01M | 2.36% |
| Dec 31, 2023 | 39.11B | 2.62B | 7.19% |
| Jan 1, 2023 | 36.49B | 114.45M | 0.31% |
| Jan 1, 2022 | 36.37B | 3.63B | 11.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| China Resources Sanjiu Medical & Pharmaceutical | 31.60B |
| Humanwell Healthcare (Group) | 23.96B |
| Zhejiang NHU Company | 22.47B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Dong-E-E-Jiao | 6.70B |
Yunnan Baiyao Group Co.,Ltd News
- 5 days ago - Fast-rising Toothpaste Newcomer Brushes Up For Hong Kong IPO - Benzinga